

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.43339370 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 6.43339370 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.36504205 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.02955851 |
| 5 | fatty acid elongation (GO:0030497) | 5.88767555 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 5.78023627 |
| 7 | central nervous system myelination (GO:0022010) | 5.78023627 |
| 8 | protein neddylation (GO:0045116) | 5.21302006 |
| 9 | respiratory electron transport chain (GO:0022904) | 5.18812495 |
| 10 | electron transport chain (GO:0022900) | 5.05084606 |
| 11 | cholesterol biosynthetic process (GO:0006695) | 4.78053726 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 4.76693971 |
| 13 | proteasome assembly (GO:0043248) | 4.53400379 |
| 14 | protein complex biogenesis (GO:0070271) | 4.28291282 |
| 15 | sterol biosynthetic process (GO:0016126) | 4.16231358 |
| 16 | nucleotide transmembrane transport (GO:1901679) | 4.04380944 |
| 17 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.00380649 |
| 18 | NADH dehydrogenase complex assembly (GO:0010257) | 4.00380649 |
| 19 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.00380649 |
| 20 | cullin deneddylation (GO:0010388) | 3.99805435 |
| 21 | signal peptide processing (GO:0006465) | 3.91487710 |
| 22 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.86969322 |
| 23 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.84207900 |
| 24 | platelet dense granule organization (GO:0060155) | 3.83174182 |
| 25 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.81151837 |
| 26 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.76751995 |
| 27 | rRNA modification (GO:0000154) | 3.73378737 |
| 28 | substantia nigra development (GO:0021762) | 3.72134316 |
| 29 | DNA deamination (GO:0045006) | 3.69268508 |
| 30 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.67701389 |
| 31 | aldehyde catabolic process (GO:0046185) | 3.67585765 |
| 32 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.67106702 |
| 33 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.67106702 |
| 34 | protein deneddylation (GO:0000338) | 3.57327791 |
| 35 | hydrogen ion transmembrane transport (GO:1902600) | 3.56474742 |
| 36 | isoprenoid biosynthetic process (GO:0008299) | 3.54359075 |
| 37 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.54114463 |
| 38 | termination of RNA polymerase III transcription (GO:0006386) | 3.54114463 |
| 39 | response to redox state (GO:0051775) | 3.47540650 |
| 40 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.41411570 |
| 41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.37911338 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.33505145 |
| 43 | ubiquinone biosynthetic process (GO:0006744) | 3.33066727 |
| 44 | proton transport (GO:0015992) | 3.30924559 |
| 45 | positive regulation of mitochondrial fission (GO:0090141) | 3.30487362 |
| 46 | ensheathment of neurons (GO:0007272) | 3.30210054 |
| 47 | axon ensheathment (GO:0008366) | 3.30210054 |
| 48 | amyloid precursor protein metabolic process (GO:0042982) | 3.28931270 |
| 49 | ATP biosynthetic process (GO:0006754) | 3.26233691 |
| 50 | myelination (GO:0042552) | 3.25903189 |
| 51 | mannosylation (GO:0097502) | 3.24836879 |
| 52 | hydrogen transport (GO:0006818) | 3.23021489 |
| 53 | cellular copper ion homeostasis (GO:0006878) | 3.22700745 |
| 54 | peptidyl-histidine modification (GO:0018202) | 3.22095587 |
| 55 | protein-cofactor linkage (GO:0018065) | 3.21071351 |
| 56 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.18236636 |
| 57 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.17728002 |
| 58 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.17466138 |
| 59 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.16364281 |
| 60 | respiratory chain complex IV assembly (GO:0008535) | 3.16335622 |
| 61 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.16022158 |
| 62 | negative regulation of ligase activity (GO:0051352) | 3.13991482 |
| 63 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.13991482 |
| 64 | regulation of mitochondrial translation (GO:0070129) | 3.10786798 |
| 65 | GPI anchor biosynthetic process (GO:0006506) | 3.10190255 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.09458800 |
| 67 | protein targeting to mitochondrion (GO:0006626) | 3.09257260 |
| 68 | intracellular protein transmembrane import (GO:0044743) | 3.08872560 |
| 69 | amino acid salvage (GO:0043102) | 3.07273682 |
| 70 | L-methionine salvage (GO:0071267) | 3.07273682 |
| 71 | L-methionine biosynthetic process (GO:0071265) | 3.07273682 |
| 72 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.05604780 |
| 73 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.03900384 |
| 74 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.03900384 |
| 75 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.03804592 |
| 76 | purine nucleotide salvage (GO:0032261) | 3.03358841 |
| 77 | regulation of collateral sprouting (GO:0048670) | 3.02683298 |
| 78 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.99691678 |
| 79 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.97678708 |
| 80 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.97678708 |
| 81 | establishment of protein localization to mitochondrion (GO:0072655) | 2.96841268 |
| 82 | copper ion homeostasis (GO:0055070) | 2.94935552 |
| 83 | 7-methylguanosine mRNA capping (GO:0006370) | 2.94846181 |
| 84 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.94340819 |
| 85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.94340819 |
| 86 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.94340819 |
| 87 | regulation of cellular amine metabolic process (GO:0033238) | 2.94023183 |
| 88 | rRNA methylation (GO:0031167) | 2.93857165 |
| 89 | ER overload response (GO:0006983) | 2.91723208 |
| 90 | ubiquinone metabolic process (GO:0006743) | 2.91065618 |
| 91 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.90742925 |
| 92 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.89591954 |
| 93 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.89511055 |
| 94 | RNA capping (GO:0036260) | 2.87864032 |
| 95 | 7-methylguanosine RNA capping (GO:0009452) | 2.87864032 |
| 96 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.87425801 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86733384 |
| 98 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.86407420 |
| 99 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.86166890 |
| 100 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.86166890 |
| 101 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.86057017 |
| 102 | C-terminal protein lipidation (GO:0006501) | 2.85789309 |
| 103 | GPI anchor metabolic process (GO:0006505) | 2.84419976 |
| 104 | iron-sulfur cluster assembly (GO:0016226) | 2.84349525 |
| 105 | metallo-sulfur cluster assembly (GO:0031163) | 2.84349525 |
| 106 | cytochrome complex assembly (GO:0017004) | 2.83222079 |
| 107 | transferrin transport (GO:0033572) | 2.83159308 |
| 108 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.82382489 |
| 109 | branched-chain amino acid catabolic process (GO:0009083) | 2.82256330 |
| 110 | GTP biosynthetic process (GO:0006183) | 2.81821344 |
| 111 | glycerophospholipid catabolic process (GO:0046475) | 2.80825961 |
| 112 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.80599910 |
| 113 | establishment of mitochondrion localization (GO:0051654) | 2.80144352 |
| 114 | base-excision repair, AP site formation (GO:0006285) | 2.79607042 |
| 115 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.79028299 |
| 116 | amyloid precursor protein catabolic process (GO:0042987) | 2.76912864 |
| 117 | adenosine metabolic process (GO:0046085) | 2.76404441 |
| 118 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.76318221 |
| 119 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.75394962 |
| 120 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.74083618 |
| 121 | nucleotide transport (GO:0006862) | 2.73958298 |
| 122 | deoxyribonucleotide catabolic process (GO:0009264) | 2.73845031 |
| 123 | purine-containing compound salvage (GO:0043101) | 2.71371440 |
| 124 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.68896690 |
| 125 | inner mitochondrial membrane organization (GO:0007007) | 2.68097468 |
| 126 | peroxisome fission (GO:0016559) | 2.67683055 |
| 127 | mitochondrial transport (GO:0006839) | 2.67630989 |
| 128 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.67215523 |
| 129 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.66243280 |
| 130 | quinone metabolic process (GO:1901661) | 2.66144754 |
| 131 | protein localization to mitochondrion (GO:0070585) | 2.65380170 |
| 132 | deoxyribose phosphate catabolic process (GO:0046386) | 2.63245375 |
| 133 | sequestering of actin monomers (GO:0042989) | 2.63241172 |
| 134 | oxidative phosphorylation (GO:0006119) | 2.62653947 |
| 135 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.61627656 |
| 136 | positive regulation of ligase activity (GO:0051351) | 2.60209800 |
| 137 | C-terminal protein amino acid modification (GO:0018410) | 2.57160121 |
| 138 | quinone biosynthetic process (GO:1901663) | 2.54179776 |
| 139 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.52171748 |
| 140 | tRNA processing (GO:0008033) | 2.49990465 |
| 141 | phagosome maturation (GO:0090382) | 2.46796690 |
| 142 | behavioral response to nicotine (GO:0035095) | 2.46796503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.59661794 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.47977498 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.39569305 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.33692016 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.94563484 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.78023696 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.63340159 |
| 8 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.60476311 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.51656255 |
| 10 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.13005130 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.99990681 |
| 12 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.99939272 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.94882582 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.82279786 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.78641179 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.50413839 |
| 17 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.36901721 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16139948 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07624303 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.98042574 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.96765821 |
| 22 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.86682264 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84450688 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83904410 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.73605757 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.73375218 |
| 27 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71066327 |
| 28 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.68776848 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67590715 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67100871 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65331356 |
| 32 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.64580076 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.63634490 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58863603 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56861817 |
| 36 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.56075023 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53882206 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.53427751 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47833403 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46913069 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46218111 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45866595 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43775918 |
| 44 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42863801 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39486014 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37328340 |
| 47 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.36424075 |
| 48 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.35193080 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34924529 |
| 50 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.33046350 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32914067 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31736266 |
| 53 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31533892 |
| 54 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.28538333 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28314314 |
| 56 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.28241345 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23537815 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21694091 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20596368 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19465958 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18756592 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.18390913 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18355746 |
| 64 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.14337601 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12222945 |
| 66 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.11766888 |
| 67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11285757 |
| 68 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.11220047 |
| 69 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.09980427 |
| 70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09767997 |
| 71 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09657477 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09187437 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08805434 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08121874 |
| 75 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05334973 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05133295 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04975446 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04837600 |
| 79 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.03858393 |
| 80 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03550976 |
| 81 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.02789364 |
| 82 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.02131913 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00956044 |
| 84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00502193 |
| 85 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00164473 |
| 86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00164473 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98719862 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96550056 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95747091 |
| 90 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95019391 |
| 91 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93324186 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92681252 |
| 93 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92190570 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91362882 |
| 95 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90898458 |
| 96 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90598020 |
| 97 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90141953 |
| 98 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89927934 |
| 99 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89194205 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88040482 |
| 101 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87911463 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87361461 |
| 103 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87176029 |
| 104 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.86775851 |
| 105 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85018143 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84761144 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84723660 |
| 108 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84123903 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83549312 |
| 110 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.83546399 |
| 111 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.82913001 |
| 112 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.82198218 |
| 113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81084185 |
| 114 | FUS_26573619_Chip-Seq_HEK293_Human | 0.80896605 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79436607 |
| 116 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.78945614 |
| 117 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.78945614 |
| 118 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78608084 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78170009 |
| 120 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77565174 |
| 121 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.76780658 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.76647057 |
| 123 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76445037 |
| 124 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.76422422 |
| 125 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.75144142 |
| 126 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.74324314 |
| 127 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.73105537 |
| 128 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.73065185 |
| 129 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.72114152 |
| 130 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71091934 |
| 131 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.69609190 |
| 132 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.69496322 |
| 133 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.68974904 |
| 134 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.67306182 |
| 135 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.67223148 |
| 136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.67030521 |
| 137 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.66988280 |
| 138 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.66037877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.79463128 |
| 2 | MP0001529_abnormal_vocalization | 3.66985178 |
| 3 | MP0000920_abnormal_myelination | 3.13561716 |
| 4 | MP0003880_abnormal_central_pattern | 3.04590298 |
| 5 | MP0001905_abnormal_dopamine_level | 2.99694768 |
| 6 | MP0003195_calcinosis | 2.38939330 |
| 7 | MP0004043_abnormal_pH_regulation | 2.36616895 |
| 8 | MP0003329_amyloid_beta_deposits | 2.31640862 |
| 9 | MP0005084_abnormal_gallbladder_morpholo | 2.20922829 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.12250267 |
| 11 | MP0006276_abnormal_autonomic_nervous | 2.12144344 |
| 12 | MP0008058_abnormal_DNA_repair | 2.10316867 |
| 13 | MP0004142_abnormal_muscle_tone | 2.09366808 |
| 14 | MP0008877_abnormal_DNA_methylation | 1.99931476 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 1.99899837 |
| 16 | MP0004270_analgesia | 1.99575846 |
| 17 | MP0005171_absent_coat_pigmentation | 1.95010103 |
| 18 | MP0004742_abnormal_vestibular_system | 1.90717399 |
| 19 | MP0005408_hypopigmentation | 1.89948086 |
| 20 | MP0000566_synostosis | 1.83133064 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.80008379 |
| 22 | MP0002163_abnormal_gland_morphology | 1.77520770 |
| 23 | MP0002272_abnormal_nervous_system | 1.76189797 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 1.76072724 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.75499372 |
| 26 | MP0003186_abnormal_redox_activity | 1.73125005 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.71909449 |
| 28 | MP0002822_catalepsy | 1.71217590 |
| 29 | MP0005379_endocrine/exocrine_gland_phen | 1.70373862 |
| 30 | MP0002736_abnormal_nociception_after | 1.67552349 |
| 31 | MP0003136_yellow_coat_color | 1.66752763 |
| 32 | MP0009764_decreased_sensitivity_to | 1.65931134 |
| 33 | MP0003634_abnormal_glial_cell | 1.65156690 |
| 34 | MP0002064_seizures | 1.63895463 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.63581426 |
| 36 | MP0004147_increased_porphyrin_level | 1.60528192 |
| 37 | MP0001727_abnormal_embryo_implantation | 1.58789632 |
| 38 | MP0006082_CNS_inflammation | 1.58534441 |
| 39 | MP0008260_abnormal_autophagy | 1.58411605 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.53990009 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.52683528 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.50854292 |
| 43 | MP0002229_neurodegeneration | 1.50171667 |
| 44 | MP0001986_abnormal_taste_sensitivity | 1.49061898 |
| 45 | MP0009785_altered_susceptibility_to | 1.46331295 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.44563226 |
| 47 | MP0009046_muscle_twitch | 1.44478915 |
| 48 | MP0001970_abnormal_pain_threshold | 1.43213218 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.42792622 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.42168269 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.39580416 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.38840107 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.36925028 |
| 54 | MP0005671_abnormal_response_to | 1.36805402 |
| 55 | MP0002638_abnormal_pupillary_reflex | 1.36766681 |
| 56 | MP0005367_renal/urinary_system_phenotyp | 1.34187831 |
| 57 | MP0000516_abnormal_urinary_system | 1.34187831 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.34097650 |
| 59 | MP0002102_abnormal_ear_morphology | 1.32581134 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.32381203 |
| 61 | MP0003724_increased_susceptibility_to | 1.32192593 |
| 62 | MP0000778_abnormal_nervous_system | 1.31951181 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.31773123 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.30566158 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.30194328 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.26817532 |
| 67 | MP0003950_abnormal_plasma_membrane | 1.26500506 |
| 68 | MP0005266_abnormal_metabolism | 1.26393851 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.23843222 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.23690115 |
| 71 | MP0005451_abnormal_body_composition | 1.23303034 |
| 72 | MP0003787_abnormal_imprinting | 1.21913624 |
| 73 | MP0009697_abnormal_copulation | 1.21551609 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.20795848 |
| 75 | MP0002295_abnormal_pulmonary_circulatio | 1.16571436 |
| 76 | MP0003718_maternal_effect | 1.16537596 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.15615498 |
| 78 | MP0005332_abnormal_amino_acid | 1.15413700 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.12321642 |
| 80 | MP0002653_abnormal_ependyma_morphology | 1.12010189 |
| 81 | MP0000604_amyloidosis | 1.11593900 |
| 82 | MP0000749_muscle_degeneration | 1.10694571 |
| 83 | MP0004133_heterotaxia | 1.10357080 |
| 84 | MP0003632_abnormal_nervous_system | 1.10307597 |
| 85 | MP0001963_abnormal_hearing_physiology | 1.09699101 |
| 86 | MP0003690_abnormal_glial_cell | 1.09110015 |
| 87 | MP0002572_abnormal_emotion/affect_behav | 1.08758059 |
| 88 | MP0002751_abnormal_autonomic_nervous | 1.08468952 |
| 89 | MP0000462_abnormal_digestive_system | 1.08233873 |
| 90 | MP0003122_maternal_imprinting | 1.07815107 |
| 91 | MP0002693_abnormal_pancreas_physiology | 1.07480685 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 1.06988813 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 1.06951852 |
| 94 | MP0008872_abnormal_physiological_respon | 1.06494000 |
| 95 | MP0000955_abnormal_spinal_cord | 1.06414899 |
| 96 | MP0001542_abnormal_bone_strength | 1.05309018 |
| 97 | MP0004924_abnormal_behavior | 1.00989207 |
| 98 | MP0005386_behavior/neurological_phenoty | 1.00989207 |
| 99 | MP0003786_premature_aging | 1.00916279 |
| 100 | MP0002132_abnormal_respiratory_system | 1.00655725 |
| 101 | MP0002277_abnormal_respiratory_mucosa | 0.99180760 |
| 102 | MP0009745_abnormal_behavioral_response | 0.97987582 |
| 103 | MP0002938_white_spotting | 0.97517013 |
| 104 | MP0004381_abnormal_hair_follicle | 0.96995903 |
| 105 | MP0001486_abnormal_startle_reflex | 0.96309127 |
| 106 | MP0002882_abnormal_neuron_morphology | 0.95662107 |
| 107 | MP0002419_abnormal_innate_immunity | 0.95457313 |
| 108 | MP0004885_abnormal_endolymph | 0.94637536 |
| 109 | MP0005646_abnormal_pituitary_gland | 0.93694168 |
| 110 | MP0008469_abnormal_protein_level | 0.93261522 |
| 111 | MP0005409_darkened_coat_color | 0.92816969 |
| 112 | MP0005365_abnormal_bile_salt | 0.92493712 |
| 113 | MP0004134_abnormal_chest_morphology | 0.92030142 |
| 114 | MP0006292_abnormal_olfactory_placode | 0.91497108 |
| 115 | MP0001853_heart_inflammation | 0.91480859 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.90043474 |
| 117 | MP0009840_abnormal_foam_cell | 0.89799465 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 0.89511275 |
| 119 | MP0005535_abnormal_body_temperature | 0.89466298 |
| 120 | MP0000358_abnormal_cell_content/ | 0.89031647 |
| 121 | MP0001501_abnormal_sleep_pattern | 0.88991741 |
| 122 | MP0000026_abnormal_inner_ear | 0.87576229 |
| 123 | MP0002184_abnormal_innervation | 0.86893662 |
| 124 | MP0002752_abnormal_somatic_nervous | 0.86574352 |
| 125 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86218744 |
| 126 | MP0005000_abnormal_immune_tolerance | 0.85669064 |
| 127 | MP0003635_abnormal_synaptic_transmissio | 0.85644313 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.85387434 |
| 129 | MP0005410_abnormal_fertilization | 0.84697878 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.84669952 |
| 131 | MP0001790_abnormal_immune_system | 0.84287057 |
| 132 | MP0005387_immune_system_phenotype | 0.84287057 |
| 133 | MP0005310_abnormal_salivary_gland | 0.83246383 |
| 134 | MP0001664_abnormal_digestion | 0.82955054 |
| 135 | MP0005025_abnormal_response_to | 0.82655401 |
| 136 | MP0000685_abnormal_immune_system | 0.82116078 |
| 137 | MP0003011_delayed_dark_adaptation | 0.80473497 |
| 138 | MP0001756_abnormal_urination | 0.80192614 |
| 139 | MP0008789_abnormal_olfactory_epithelium | 0.79977622 |
| 140 | MP0003252_abnormal_bile_duct | 0.79868358 |
| 141 | MP0000538_abnormal_urinary_bladder | 0.79625197 |
| 142 | MP0002723_abnormal_immune_serum | 0.78201114 |
| 143 | MP0003075_altered_response_to | 0.77648488 |
| 144 | MP0000343_altered_response_to | 0.77061603 |
| 145 | MP0005376_homeostasis/metabolism_phenot | 0.76962809 |
| 146 | MP0010030_abnormal_orbit_morphology | 0.76516794 |
| 147 | MP0002090_abnormal_vision | 0.76300779 |
| 148 | MP0002452_abnormal_antigen_presenting | 0.75718441 |
| 149 | MP0002138_abnormal_hepatobiliary_system | 0.74608700 |
| 150 | MP0005253_abnormal_eye_physiology | 0.74504032 |
| 151 | MP0001764_abnormal_homeostasis | 0.73233369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased serum pyruvate (HP:0003542) | 5.78573645 |
| 2 | Abnormality of glycolysis (HP:0004366) | 5.78573645 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 5.54467309 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.99882041 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.89656887 |
| 6 | Acute encephalopathy (HP:0006846) | 4.71299895 |
| 7 | Progressive macrocephaly (HP:0004481) | 4.45648603 |
| 8 | Increased CSF lactate (HP:0002490) | 4.15601696 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.15147590 |
| 10 | Renal Fanconi syndrome (HP:0001994) | 4.05520757 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.87166176 |
| 12 | Hepatic necrosis (HP:0002605) | 3.84000607 |
| 13 | Cerebral edema (HP:0002181) | 3.57877543 |
| 14 | Leukodystrophy (HP:0002415) | 3.57660084 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.56852132 |
| 16 | Parakeratosis (HP:0001036) | 3.51816286 |
| 17 | Abnormality of the anterior horn cell (HP:0006802) | 3.39653521 |
| 18 | Degeneration of anterior horn cells (HP:0002398) | 3.39653521 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.32733895 |
| 20 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.30219068 |
| 21 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.22897777 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.17349111 |
| 23 | Increased intramyocellular lipid droplets (HP:0012240) | 3.05852194 |
| 24 | Pheochromocytoma (HP:0002666) | 3.05311329 |
| 25 | Respiratory failure (HP:0002878) | 3.04445778 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.02204090 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00388876 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00388876 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00388876 |
| 30 | Lactic acidosis (HP:0003128) | 2.98785373 |
| 31 | Neuroendocrine neoplasm (HP:0100634) | 2.98258192 |
| 32 | Type I transferrin isoform profile (HP:0003642) | 2.93800273 |
| 33 | Exercise intolerance (HP:0003546) | 2.90630479 |
| 34 | Neurofibrillary tangles (HP:0002185) | 2.88478148 |
| 35 | Increased serum lactate (HP:0002151) | 2.87599723 |
| 36 | Glycosuria (HP:0003076) | 2.85327573 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 2.85327573 |
| 38 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.82452194 |
| 39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.82452194 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.74620913 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.74250820 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.74250820 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.70969374 |
| 44 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.69757753 |
| 45 | Abnormality of renal resorption (HP:0011038) | 2.65967250 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 2.65512286 |
| 47 | Hyperphosphaturia (HP:0003109) | 2.63354382 |
| 48 | Optic disc pallor (HP:0000543) | 2.59110848 |
| 49 | Abnormal protein glycosylation (HP:0012346) | 2.59093549 |
| 50 | Abnormal glycosylation (HP:0012345) | 2.59093549 |
| 51 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.59093549 |
| 52 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.59093549 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.58666772 |
| 54 | Stomatitis (HP:0010280) | 2.54075985 |
| 55 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.52969180 |
| 56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.52969180 |
| 57 | Pancreatic cysts (HP:0001737) | 2.52597782 |
| 58 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.44566530 |
| 59 | Aplastic anemia (HP:0001915) | 2.44493712 |
| 60 | Opisthotonus (HP:0002179) | 2.38037013 |
| 61 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37991587 |
| 62 | Pancreatic fibrosis (HP:0100732) | 2.34930378 |
| 63 | Spastic paraparesis (HP:0002313) | 2.34624588 |
| 64 | Exertional dyspnea (HP:0002875) | 2.33667965 |
| 65 | Abnormality of alanine metabolism (HP:0010916) | 2.32254224 |
| 66 | Hyperalaninemia (HP:0003348) | 2.32254224 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32254224 |
| 68 | Respiratory difficulties (HP:0002880) | 2.31063139 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28930107 |
| 70 | Gait imbalance (HP:0002141) | 2.28556586 |
| 71 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.28053703 |
| 72 | Hypokalemic alkalosis (HP:0001949) | 2.26283416 |
| 73 | Hyperglycinemia (HP:0002154) | 2.25090050 |
| 74 | Microvesicular hepatic steatosis (HP:0001414) | 2.23142765 |
| 75 | CNS demyelination (HP:0007305) | 2.22919284 |
| 76 | True hermaphroditism (HP:0010459) | 2.19819262 |
| 77 | Abnormal urine phosphate concentration (HP:0012599) | 2.16488917 |
| 78 | Congenital primary aphakia (HP:0007707) | 2.15948952 |
| 79 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10295327 |
| 80 | CNS hypomyelination (HP:0003429) | 2.07400519 |
| 81 | X-linked dominant inheritance (HP:0001423) | 2.07178978 |
| 82 | Autoamputation (HP:0001218) | 2.06909326 |
| 83 | Methylmalonic aciduria (HP:0012120) | 2.05823630 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05393004 |
| 85 | Lethargy (HP:0001254) | 2.04808610 |
| 86 | Upper motor neuron abnormality (HP:0002127) | 2.04387649 |
| 87 | Vaginal atresia (HP:0000148) | 2.03904606 |
| 88 | Renal tubular dysfunction (HP:0000124) | 1.98962222 |
| 89 | Mutism (HP:0002300) | 1.98275621 |
| 90 | Progressive microcephaly (HP:0000253) | 1.97013384 |
| 91 | Methylmalonic acidemia (HP:0002912) | 1.96878601 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 1.96504399 |
| 93 | Abnormal pupillary function (HP:0007686) | 1.96418987 |
| 94 | Genital tract atresia (HP:0001827) | 1.93516759 |
| 95 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92904080 |
| 96 | Hypothermia (HP:0002045) | 1.92749668 |
| 97 | Abnormality of the corticospinal tract (HP:0002492) | 1.92262270 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92204467 |
| 99 | Cerebral hemorrhage (HP:0001342) | 1.89605953 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89296476 |
| 101 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88899298 |
| 102 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87655522 |
| 103 | Pancytopenia (HP:0001876) | 1.86938436 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 1.86624653 |
| 105 | Emotional lability (HP:0000712) | 1.85379281 |
| 106 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.85087925 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 1.84623251 |
| 108 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84216723 |
| 109 | Amniotic constriction ring (HP:0009775) | 1.83183877 |
| 110 | Abnormality of placental membranes (HP:0011409) | 1.83183877 |
| 111 | Prolonged neonatal jaundice (HP:0006579) | 1.83101718 |
| 112 | Reduced antithrombin III activity (HP:0001976) | 1.82605614 |
| 113 | Nephronophthisis (HP:0000090) | 1.81992598 |
| 114 | Hypoplastic pelvis (HP:0008839) | 1.81946297 |
| 115 | Split foot (HP:0001839) | 1.81945024 |
| 116 | Poor suck (HP:0002033) | 1.81329616 |
| 117 | Ketosis (HP:0001946) | 1.81268104 |
| 118 | Abnormality of serum amino acid levels (HP:0003112) | 1.80791037 |
| 119 | Adrenal hypoplasia (HP:0000835) | 1.80657495 |
| 120 | Cerebral palsy (HP:0100021) | 1.80395428 |
| 121 | Ketoacidosis (HP:0001993) | 1.76960274 |
| 122 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.76644662 |
| 123 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76381951 |
| 124 | Renal salt wasting (HP:0000127) | 1.75493668 |
| 125 | Myokymia (HP:0002411) | 1.73968893 |
| 126 | Cerebral inclusion bodies (HP:0100314) | 1.73203633 |
| 127 | Blindness (HP:0000618) | 1.72365279 |
| 128 | Gliosis (HP:0002171) | 1.71671440 |
| 129 | Hypoplastic left heart (HP:0004383) | 1.71282005 |
| 130 | Sensory axonal neuropathy (HP:0003390) | 1.70402362 |
| 131 | Limb dystonia (HP:0002451) | 1.69641273 |
| 132 | Postnatal microcephaly (HP:0005484) | 1.69498065 |
| 133 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.68775019 |
| 134 | Single umbilical artery (HP:0001195) | 1.68775019 |
| 135 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.68775019 |
| 136 | Hypoplasia of the uterus (HP:0000013) | 1.68135170 |
| 137 | Vomiting (HP:0002013) | 1.67877257 |
| 138 | Stenosis of the external auditory canal (HP:0000402) | 1.66364226 |
| 139 | Constricted visual fields (HP:0001133) | 1.66097359 |
| 140 | Congenital, generalized hypertrichosis (HP:0004540) | 1.66093996 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 1.65466031 |
| 142 | Nausea (HP:0002018) | 1.65465743 |
| 143 | Oculomotor apraxia (HP:0000657) | 1.64934712 |
| 144 | Agitation (HP:0000713) | 1.63300932 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.63170169 |
| 146 | Akinesia (HP:0002304) | 1.62650814 |
| 147 | Anteriorly placed anus (HP:0001545) | 1.60951257 |
| 148 | Septate vagina (HP:0001153) | 1.58574800 |
| 149 | Hepatosplenomegaly (HP:0001433) | 1.58484656 |
| 150 | Delusions (HP:0000746) | 1.58458465 |
| 151 | Dicarboxylic aciduria (HP:0003215) | 1.57691304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.79588139 |
| 2 | STK16 | 3.39208377 |
| 3 | OXSR1 | 3.29593230 |
| 4 | PBK | 2.96726862 |
| 5 | ARAF | 2.88931682 |
| 6 | BCR | 2.86934441 |
| 7 | VRK2 | 2.80502289 |
| 8 | FRK | 2.79352424 |
| 9 | BUB1 | 2.73390966 |
| 10 | NME1 | 2.67093899 |
| 11 | LIMK1 | 2.51920773 |
| 12 | WNK4 | 2.33548577 |
| 13 | MST4 | 2.21162165 |
| 14 | MAP4K2 | 2.18344700 |
| 15 | NUAK1 | 2.12499442 |
| 16 | TESK2 | 2.11752120 |
| 17 | DYRK2 | 2.07403345 |
| 18 | BRAF | 2.00606715 |
| 19 | CDK19 | 1.99412463 |
| 20 | MAPKAPK5 | 1.97042687 |
| 21 | CASK | 1.85384409 |
| 22 | EIF2AK3 | 1.82304498 |
| 23 | PDK2 | 1.77634987 |
| 24 | EIF2AK1 | 1.73890733 |
| 25 | MARK1 | 1.68218323 |
| 26 | CSNK1G3 | 1.66610002 |
| 27 | TAOK3 | 1.58613054 |
| 28 | UHMK1 | 1.54117338 |
| 29 | EPHB1 | 1.50746449 |
| 30 | BCKDK | 1.39395119 |
| 31 | MET | 1.39351143 |
| 32 | PIM2 | 1.38413484 |
| 33 | TRIM28 | 1.33162808 |
| 34 | BMPR1B | 1.31494788 |
| 35 | KDR | 1.30776982 |
| 36 | VRK1 | 1.29955280 |
| 37 | CAMK2B | 1.18213272 |
| 38 | PHKG1 | 1.16965806 |
| 39 | LMTK2 | 1.14405764 |
| 40 | MYLK | 1.13605502 |
| 41 | CSNK1A1L | 1.09655938 |
| 42 | CSNK1G2 | 1.06550010 |
| 43 | GRK1 | 1.05811759 |
| 44 | PKN1 | 1.05417635 |
| 45 | NME2 | 1.05084174 |
| 46 | IRAK2 | 1.04887084 |
| 47 | CSNK1G1 | 1.02033872 |
| 48 | CAMK2D | 1.00810595 |
| 49 | TXK | 0.98707434 |
| 50 | WNK3 | 0.98187978 |
| 51 | CAMKK2 | 0.95526340 |
| 52 | ABL2 | 0.94173572 |
| 53 | BLK | 0.93388795 |
| 54 | NEK6 | 0.93017124 |
| 55 | KIT | 0.92912608 |
| 56 | ADRBK2 | 0.92633430 |
| 57 | INSRR | 0.91767650 |
| 58 | ROCK2 | 0.90411058 |
| 59 | IKBKB | 0.87526641 |
| 60 | TESK1 | 0.87009474 |
| 61 | CAMK2G | 0.85839390 |
| 62 | PLK2 | 0.85285693 |
| 63 | OBSCN | 0.85081473 |
| 64 | GRK7 | 0.84540727 |
| 65 | PRKCE | 0.79278818 |
| 66 | SGK223 | 0.78844494 |
| 67 | SGK494 | 0.78844494 |
| 68 | FES | 0.78332160 |
| 69 | PRPF4B | 0.77753756 |
| 70 | TNIK | 0.77210455 |
| 71 | CDK14 | 0.76566214 |
| 72 | AURKA | 0.75405515 |
| 73 | PINK1 | 0.71592549 |
| 74 | MAP3K12 | 0.70848094 |
| 75 | TSSK6 | 0.70267744 |
| 76 | IRAK1 | 0.70073546 |
| 77 | MUSK | 0.67371250 |
| 78 | MAPK15 | 0.66978222 |
| 79 | DAPK1 | 0.65857338 |
| 80 | PAK3 | 0.65575398 |
| 81 | CDK18 | 0.65143661 |
| 82 | CCNB1 | 0.64964167 |
| 83 | MKNK1 | 0.64309980 |
| 84 | PIK3CG | 0.64214440 |
| 85 | GRK5 | 0.64196266 |
| 86 | MAPK13 | 0.63770059 |
| 87 | PAK1 | 0.61958815 |
| 88 | CAMK2A | 0.61316598 |
| 89 | TNK2 | 0.60552164 |
| 90 | FGFR2 | 0.60219031 |
| 91 | DAPK2 | 0.60005689 |
| 92 | CDK15 | 0.58838251 |
| 93 | SYK | 0.58774627 |
| 94 | MAP2K2 | 0.58661461 |
| 95 | MAP3K11 | 0.58337562 |
| 96 | ERBB3 | 0.58209371 |
| 97 | ILK | 0.56904227 |
| 98 | RPS6KA5 | 0.56098537 |
| 99 | MAPKAPK3 | 0.55729199 |
| 100 | LYN | 0.52786823 |
| 101 | CDK11A | 0.52260285 |
| 102 | PRKCQ | 0.51903267 |
| 103 | MINK1 | 0.51326422 |
| 104 | ADRBK1 | 0.50163841 |
| 105 | PLK4 | 0.49028092 |
| 106 | NEK1 | 0.48938233 |
| 107 | ERBB4 | 0.48677215 |
| 108 | SRPK1 | 0.48226987 |
| 109 | TLK1 | 0.47738630 |
| 110 | MAP3K4 | 0.47538393 |
| 111 | ACVR1B | 0.47488944 |
| 112 | MAP2K7 | 0.46183367 |
| 113 | NTRK1 | 0.45755985 |
| 114 | FGR | 0.45572818 |
| 115 | AKT3 | 0.45088324 |
| 116 | TEC | 0.44431871 |
| 117 | PNCK | 0.43819676 |
| 118 | PLK3 | 0.43592602 |
| 119 | MAP2K6 | 0.43115413 |
| 120 | IRAK3 | 0.42433377 |
| 121 | PRKCI | 0.41652948 |
| 122 | PRKCA | 0.41309577 |
| 123 | TBK1 | 0.41242373 |
| 124 | CSNK2A2 | 0.41194544 |
| 125 | BMPR2 | 0.40192747 |
| 126 | ZAK | 0.39160753 |
| 127 | DAPK3 | 0.38873566 |
| 128 | MATK | 0.38178885 |
| 129 | PLK1 | 0.37876416 |
| 130 | CSNK1A1 | 0.37200778 |
| 131 | CDK5 | 0.36881662 |
| 132 | PRKG1 | 0.36836000 |
| 133 | PRKACA | 0.34398411 |
| 134 | PRKCG | 0.32304332 |
| 135 | CSNK2A1 | 0.32210084 |
| 136 | PHKG2 | 0.30558772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.81286983 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.20028180 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.95198445 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.70020263 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.62205369 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.98856299 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.96605866 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.84386125 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.83782674 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.58905937 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.38384263 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.34289376 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.31339585 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.31098384 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.16571096 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 1.98299698 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.78012386 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.73742939 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.68817619 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.55601525 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53704503 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44815675 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44173682 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37327603 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.30257511 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29105159 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28794456 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27905689 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26077264 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22663229 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19955086 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19250153 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18972001 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16901146 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13672822 |
| 36 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13019444 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12676960 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11455493 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.09613593 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.08672007 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.07719338 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06133337 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.04770325 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.02347046 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00087315 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 0.99478502 |
| 47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.98856131 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98610063 |
| 49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.97999666 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.97428562 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90282869 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88136076 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87264099 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86031519 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85954212 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84496227 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 0.82147707 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79144225 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78010441 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76426751 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.75638557 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75031465 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73708144 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70394790 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68241822 |
| 66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67040921 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65234337 |
| 68 | Purine metabolism_Homo sapiens_hsa00230 | 0.64643459 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63762124 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63594588 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62627123 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62203522 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62136050 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61755784 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61686724 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.61419202 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60815437 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59255865 |
| 79 | Mismatch repair_Homo sapiens_hsa03430 | 0.59150337 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58576302 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56913606 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55418949 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53465746 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50120223 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48520348 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47275752 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46911923 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45702213 |
| 89 | DNA replication_Homo sapiens_hsa03030 | 0.45482181 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43682589 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42399921 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41694187 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41210005 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40688941 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39432093 |
| 96 | RNA transport_Homo sapiens_hsa03013 | 0.39166736 |
| 97 | Spliceosome_Homo sapiens_hsa03040 | 0.39139397 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39137436 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38308726 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37886986 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35925469 |
| 102 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34819321 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33864600 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33811770 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32262755 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31131203 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28406903 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27632963 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27123566 |
| 110 | Cocaine addiction_Homo sapiens_hsa05030 | 0.26672704 |
| 111 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25407194 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25147303 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24149587 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19946502 |
| 115 | Homologous recombination_Homo sapiens_hsa03440 | 0.17924400 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17601269 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17250768 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17137299 |
| 119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.16928105 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16896522 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.16030200 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15785016 |
| 123 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.14087058 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.13782881 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.11150221 |
| 126 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.10753307 |
| 127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10324788 |
| 128 | Taste transduction_Homo sapiens_hsa04742 | 0.08868527 |

